Inno Biologics and CEVEC Sign License Agreement for Human CAP Technology
10-Dec-2009
- Malaysia
“After launching our new cell line in the U.S. and European market we are delighted to have now our first customers in Asia/Pacific working with our cells. With expression rates and protein quality outperforming any other human system on the market we are proud to have Inno Biologics working with our unique, state of the art cell line,” Wolfgang Kintzel, Managing Director of CEVEC, comments.
Most read news
Organizations
Other news from the department business & finance
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.